Cutaneous squamous cell carcinoma (cSCC) is the second most common malignant skin tumor. Early and precise diagnosis of tumor staging is crucial for long-term outcomes. While pathological diagnosis has traditionally served as the gold standard, the assessment of differentiation levels heavily depends on subjective judgments. Therefore, how to improve the diagnosis accuracy and objectivity of pathologists has become an urgent problem to be solved. We used multispectral imaging (MSI) to enhance tumor classification. The hematoxylin and eosin (H&E) stained cSCC slides were from Shanghai Ruijin Hospital. Scale-invariant feature transform was applied to multispectral images for image stitching, while the adaptive threshold segmentation method and random forest segmentation method were used for image segmentation, respectively. Synthetic pseudo-color images effectively highlight tissue differences. Quantitative analysis confirms significant variation in the nuclear area between normal and cSCC tissues (p < 0.001), supported by an AUC of 1 in ROC analysis. The AUC within cSCC tissues is 0.57. Further study shows higher nuclear atypia in poorly differentiated cSCC tissues compared to well-differentiated cSCC (p < 0.001), also with an AUC of 1. Lastly, well differentiated cSCC tissues show more and larger keratin pearls. These results have shown that combined MSI with imaging processing techniques will improve H&E stained human cSCC diagnosis accuracy, and it will be well utilized to distinguish histopathological staging features.
26 January 2026 in Journal of Innovative Optical Health Sciences
In recent years, the rapid advancement of artificial intelligence (AI) technology has enabled AI-assisted negative screening to significantly enhance physicians’ efficiency through image feature analysis and multimodal data modeling, allowing them to focus more on diagnosing positive cases. Meanwhile, multispectral imaging (MSI) integrates spectral and spatial resolution to capture subtle tissue features invisible to the human eye, providing high-resolution data support for pathological analysis. Combining AI technology with MSI and employing quantitative methods to analyze multiband biomarkers (such as absorbance differences in keratin pearls) can effectively improve diagnostic specificity and reduce subjective errors in manual slide interpretation. To address the challenge of identifying negative tissue sections, we developed a discrimination algorithm powered by MSI. We demonstrated its efficacy using cutaneous squamous cell carcinoma (cSCC) as a representative case study. The algorithm achieved 100% accuracy in excluding negative cases and effectively mitigated the false-positive problem caused by cSCC heterogeneity. We constructed a multispectral image (MSI) dataset acquired at 520[ ]nm, 600[ ]nm, and 630[ ]nm wavelengths. Subsequently, we employed an optimized MobileViT model for tissue classification and performed comparative analyses against other models. The experimental results showed that our optimized MobileViT model achieved superior performance in identifying negative tissue sections, with a perfect accuracy rate of 100%. Thus, our results confirm the feasibility of integrating MSI with AI to exclude negative cases with perfect accuracy, offering a novel solution to alleviate the workload of pathologists.